Loading…
Cellebrite DI Ltd. is projected to rise to $19.64 by 2027, a +35% move from its current price of $14.57. CLBT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $14.24 | $14.58 | $14.93 | +0.07% |
| Aug 2 | $14.10 | $14.59 | $15.09 | +0.13% |
| Aug 3 | $14.01 | $14.60 | $15.22 | +0.20% |
| Aug 4 | $13.93 | $14.61 | $15.32 | +0.26% |
| Aug 5 | $13.86 | $14.62 | $15.42 | +0.33% |
| Aug 6 | $13.80 | $14.63 | $15.51 | +0.39% |
| Aug 7 | $13.74 | $14.64 | $15.59 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.74 | $14.64 | $15.59 | +0.46% |
| Week 2 | $13.45 | $14.70 | $16.08 | +0.92% |
| Week 3 | $13.24 | $14.77 | $16.48 | +1.39% |
| Week 4 | $13.08 | $14.84 | $16.84 | +1.85% |
| Week 5 | $12.94 | $14.91 | $17.17 | +2.32% |
| Week 6 | $12.83 | $14.98 | $17.49 | +2.79% |
| Week 7 | $12.73 | $15.05 | $17.79 | +3.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency.
It is headquartered in Petah Tikva, Israel. The company also offers professional services, such as training and certification services, and advanced services, serving federal, state, and local agencies, as well as corporations and service providers. The description confirms its focus within the Technology sector and its regional scope of operations.
Cellebrite DI Ltd. (CLBT) is a technology stock with a current price of $14.18 and a market cap of $3.54B, ranking 1575. These figures place the company in a mid-sized market position with a global client base supporting legally sanctioned digital investigations.
The forecasted price path shows an evolving upside from 2026 onward, with the average price rising over time. For example, the 2026 average is $14.18 and the long-range outlook projects substantial growth by 2040 and 2050, with the 2040 average at $66.46 and the 2050 average at $115.11. The corresponding max prices in later years imply meaningful upside, with the 2050 max listed at $209.50.
The forecast also outlines rising ROIs, from 0% in 2026 to as high as 711.8% by 2050, and a persistent bullish sentiment from 2027 onward. While these are estimates, they illustrate a path of strong upside potential against the current price level.
A major floor 29.0% below — a decisive break under it would weaken the trend.
The nearest floor, 14.8% below — buyers have tended to step in here.
The nearest ceiling, 14.0% above — a clean break opens room to run.
A major ceiling 28.5% above — clearing it would confirm fresh momentum.
Key CLBT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLBT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.67 | Sell | $14.72 | Sell |
| MA 10 | $14.71 | Sell | $14.82 | Sell |
| MA 20 | $15.43 | Sell | $14.86 | Sell |
| MA 50 | $14.26 | Buy | $14.47 | Buy |
| MA 100 | $13.86 | Buy | $14.41 | Buy |
| MA 200 | $15.31 | Sell | $14.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.60 | Neutral |
| Stoch RSI (14) | 25.06 | Neutral |
| CCI (20) | -80.05 | Neutral |
| Williams %R (14) | -75.94 | Info |
| MACD (12,26,9) | -0.16 | Sell |
| ROC (12) | -9.95 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 24.06 | Neutral |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 43.93 | Neutral |
| Momentum (10) | -1.26 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 14.90 | Sell |
| ADX (14) | 16.26 | Neutral |
| ATR (14) | 0.32 | Info |
The 30-day technical picture is NEUTRAL, with RSI(14) at 40. The moving average backdrop shows SMA50 at $14.07 and SMA200 at $15.44, indicating modest pricing momentum around the current level.
The near-term range for the last 30 days spans from a low of $11.93 to a high of $16.85, suggesting a broad trading range. Key immediate levels are a support at $12.42 and a resistance at $16.61, which could frame short-term price moves as volatility fluctuates within the range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.03 | $14.57 | $20.17 | 0% | Neutral | |
| $15.84 | $19.64 | $25.63 | +35% | Bullish | |
| $18.59 | $23.62 | $31.88 | +62% | Bullish | |
| $19.38 | $25.12 | $34.80 | +72% | Bullish | |
| $19.62 | $25.89 | $36.67 | +78% | Bullish | |
| $21.04 | $28.21 | $40.73 | +94% | Bullish | |
| $23.52 | $32.00 | $47.00 | +120% | Bullish | |
| $28.08 | $38.74 | $57.80 | +166% | Bullish | |
| $30.03 | $41.98 | $63.55 | +188% | Bullish | |
| $31.50 | $44.60 | $68.41 | +206% | Bullish | |
| $45.79 | $68.60 | $111.31 | +371% | Bullish | |
| $73.89 | $121.81 | $214.66 | +736% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.03 | $14.57 | $16.99 | +0.00% |
| August 2026 | $13.02 | $15.24 | $18.23 | +4.61% |
| September 2026 | $13.12 | $15.47 | $18.72 | +1.48% |
| October 2026 | $12.90 | $15.30 | $18.69 | -1.09% |
| November 2026 | $13.14 | $15.66 | $19.27 | +2.33% |
| December 2026 | $13.60 | $16.28 | $20.17 | +3.97% |
Click any year to see its month-by-month CLBT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CLBT price prediction for 2026 points to an average of $14.57 (low $11.03, high $20.17) — a potential gain of 0% on today's $14.57. Price action looks broadly range-bound.
In 2027, CLBT is projected to trade between $15.84 and $25.63, averaging $19.64 — a potential gain of +35% from today's $14.57. That is up +35% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Cellebrite DI Ltd.'s 2028 outlook centres on $23.62, within a $18.59 to $31.88 range. That is up +20% on the projected 2027 average. That marks a +62% change versus current levels. Momentum favours further upside here.
By 2029, CLBT could reach as high as $34.80, with a base case around $25.12 and support toward $19.38 — roughly +72% from $14.57. Buyers look set to stay in control over this stretch.
Expect CLBT to range from $19.62 to $36.67 through 2030. The $25.89 average target implies a +78% move from current prices. That is up +3% on the projected 2029 average. Momentum favours further upside here.
The CLBT price prediction for 2031 points to an average of $28.21 (low $21.04, high $40.73) — a potential gain of +94% on today's $14.57. Buyers look set to stay in control over this stretch.
In 2032, CLBT is projected to trade between $23.52 and $47.00, averaging $32.00 — a potential gain of +120% from today's $14.57. That is up +13% on the projected 2031 average. Momentum favours further upside here.
Cellebrite DI Ltd.'s 2033 outlook centres on $38.74, within a $28.08 to $57.80 range. That is up +21% on the projected 2032 average. That marks a +166% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CLBT could reach as high as $63.55, with a base case around $41.98 and support toward $30.03 — roughly +188% from $14.57. Momentum favours further upside here.
Expect CLBT to range from $31.50 to $68.41 through 2035. The $44.60 average target implies a +206% move from current prices. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The CLBT price prediction for 2040 points to an average of $68.60 (low $45.79, high $111.31) — a potential gain of +371% on today's $14.57. Momentum favours further upside here.
In 2050, CLBT is projected to trade between $73.89 and $214.66, averaging $121.81 — a potential gain of +736% from today's $14.57. That is up +78% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLBT today (≈ 68.63418 CLBT) could be worth
$8,360.6
+$7,360.6 (+736%) by 2050 · US Dollar
Based on the average projected CLBT price of $121.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLBTwould be worth at today's price.
$1,000 invested in CLBT on Jul 30, 2025 (≈ 70.175439 CLBT) would be worth
$1,022.46
+$22.46 (+2.2%) today · 1.02× · US Dollar
Based on a CLBT entry price of $14.25 vs. today's $14.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.06 | $1,036.27 | +3.6% |
| 1 month ago | $14.6 | $997.95 | -0.2% |
| 3 months ago | $13.35 | $1,091.39 | +9.1% |
| 6 months ago | $14.71 | $990.48 | -1.0% |
| 1 year ago | $14.25 | $1,022.46 | +2.2% |
| All time (5.0y) ago | $9.92 | $1,468.75 | +46.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLBT forecast.
Our base-case forecast reaches $29.00 around 2032.
Implied market cap at $29.00: $7.23B
The multi-year forecast paints a bullish arc for Cellebrite DI Ltd. In 2026, the min, avg, and max are $11.03, $14.18, and $19.94 respectively, with an ROI of 0 and a NEUTRAL sentiment.
From 2027 onward, the averages trend higher: 2027 avg $19.21 (ROI 35.5, BULLISH), 2028 avg $23.43 (ROI 65.2, BULLISH), 2029 avg $24.49 (ROI 72.7, BULLISH), 2030 avg $24.80 (ROI 74.9, BULLISH), 2031 avg $27.47 (ROI 93.8, BULLISH), 2032 avg $30.84 (ROI 117.5, BULLISH), 2033 avg $37.28 (ROI 162.9, BULLISH), 2034 avg $40.94 (ROI 188.8, BULLISH), 2035 avg $42.95 (ROI 202.9, BULLISH).
In the longer horizon, 2040 yields an average of $66.46 (ROI 368.7, BULLISH) and 2050 reaches an average of $115.11 (ROI 711.8, BULLISH). These are estimates and not guarantees; they reflect a forecast path with meaningful upside but also inherent uncertainty and risk in asset prices.
Tap a question to reveal the answer.
Avg price $24.80; ROI 74.9%; sentiment BULLISH.
The forecast shows a bullish path with rising averages and positive ROI, including 2027 avg $19.21 (ROI 35.5) and 2050 avg $115.11 (ROI 711.8), though these are estimates and not guarantees.
Yes. The forecast max in 2033 is $56.82 and in 2034 is $63.38, indicating the possibility of exceeding $50 by 2033.
Current price $14.18; Market cap $3.54B.
30-day range low $11.93, high $16.85; support $12.42; resistance $16.61.
Cellebrite DI Ltd. Community Discussion
0Share your Cellebrite DI Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.